BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20815987)

  • 1. [Clinical significance of determination of serum B7-H4 in patients with malignant hematologic diseases].
    Wang XM; Hu GY; Liu W; Zheng SH; Lv J; Wang HM; Xu JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Sep; 26(9):893-4. PubMed ID: 20815987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.
    Simon I; Zhuo S; Corral L; Diamandis EP; Sarno MJ; Wolfert RL; Kim NW
    Cancer Res; 2006 Feb; 66(3):1570-5. PubMed ID: 16452214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
    Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
    Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
    Zhong M; Liu W
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum haptoglobin level in disseminated malignant diseases in children.
    Moe PJ
    Acta Paediatr Scand; 1970 Jul; 59(4):381-4. PubMed ID: 5447681
    [No Abstract]   [Full Text] [Related]  

  • 6. Ectopic B7-H4-Ig expression attenuates concanavalin A-induced hepatic injury.
    Xu JF; Xiao H; Hu GY; Zheng SH; Liu W; Yuan CL; Yang H; Lü J; Zheng F; Wang CY; Gong FL
    Clin Immunol; 2010 Jul; 136(1):30-41. PubMed ID: 20346734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [B7-H4 expression of salivary gland and sera in patients with primary Sjogren's syndrome].
    Yu DL; Li XM; Wang XM; Wang XQ; Li XP
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(39):2775-7. PubMed ID: 23290167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha 1-microglobulin levels in diseases of the hematopoietic system.
    Kageyama T; Ohyabu H
    Bull Osaka Med Sch; 1987 Jul; 33(1):71-5. PubMed ID: 2469510
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating B7-H4 in serum predicts prognosis in patients with hepatocellular carcinoma.
    Zhang SA; Wu ZX; Zhang X; Zeng ZY; Li DL
    Genet Mol Res; 2015 Oct; 14(4):13041-8. PubMed ID: 26505457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of co-stimulatory molecules B7-H4 expression on the prognosis of patients with gastric cancer treated with cytokine-induced killer cells adoptive immunotherapy].
    Jiang JT; Wu CP; Shen YP; Zheng L; Wu J; Ji M; Xu B; Chen LJ; Wu YG; Zheng X; Zhu YB; Lu BF; Zhang XG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 May; 13(5):366-70. PubMed ID: 20499308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.
    Dong Q; Ma X
    Biomed Res Int; 2015; 2015():156432. PubMed ID: 25954746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of stromal cell derived factor-1(SDF-1) and its receptor CXCR4 in hematologic malignancies].
    Zeng DF; Kong PY; Chen XH; Peng XG; Wei L; Chang C; Liu L; Liu H; Wang QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):274-7. PubMed ID: 15854291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis.
    Arigami T; Uenosono Y; Hirata M; Hagihara T; Yanagita S; Ishigami S; Natsugoe S
    J Surg Oncol; 2010 Dec; 102(7):748-52. PubMed ID: 20872810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.
    Miyatake T; Tringler B; Liu W; Liu SH; Papkoff J; Enomoto T; Torkko KC; Dehn DL; Swisher A; Shroyer KR
    Gynecol Oncol; 2007 Jul; 106(1):119-27. PubMed ID: 17509674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of sB7-H4 in Serum and Lymphoma Tissues of Patients with Malignant Lymphoma and Its Value for Diagnosis and Re-Examine of Lymphoma].
    Liang XP; Yang HL; Shao MM; Li N; Li XF; Liu B; Li HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1355-1359. PubMed ID: 30295250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of serum B7-H4 for hepatocellular carcinoma.
    Zhang C; Li Y; Wang Y
    J Surg Res; 2015 Aug; 197(2):301-6. PubMed ID: 25963168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
    Simon I; Katsaros D; Rigault de la Longrais I; Massobrio M; Scorilas A; Kim NW; Sarno MJ; Wolfert RL; Diamandis EP
    Gynecol Oncol; 2007 Aug; 106(2):334-41. PubMed ID: 17498784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].
    Poreba M; Jaźwiec B; Kuliczkowski K; Poreba R
    Pol Arch Med Wewn; 2005 Jan; 113(1):27-34. PubMed ID: 16130598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological heterogeneity in human ferritinemia.
    Asakawa H; Taguchi T; Mori W
    Gan; 1976 Jun; 67(3):347-53. PubMed ID: 63405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.